AU2002340549A1 - Stents - Google Patents

Stents

Info

Publication number: AU2002340549A1
Authority: AU; Australia
Prior art keywords: stents
Prior art date: 2001-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002340549A

Other versions

AU2002340549B2 (en

Inventor

Jochen Kalbe

Wolfram Ledwoch

Didier Meulien

Elisabeth Perzborn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee

Bayer Schering Pharma AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-24

Filing date

2002-10-11

Publication date

2003-07-03

2001-10-24 Priority claimed from DE10152460A external-priority patent/DE10152460A1/en

2002-10-11 Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG

2003-07-03 Publication of AU2002340549A1 publication Critical patent/AU2002340549A1/en

2007-11-29 Application granted granted Critical

2007-11-29 Publication of AU2002340549B2 publication Critical patent/AU2002340549B2/en

2009-05-14 Assigned to BAYER SCHERING PHARMA AKTIENGESELLSCHAFT reassignment BAYER SCHERING PHARMA AKTIENGESELLSCHAFT Request for Assignment Assignors: BAYER HEALTHCARE AG

2022-10-11 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002340549A 2001-10-24 2002-10-11 Stents Ceased AU2002340549B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10152460.9		2001-10-24
DE10152460A DE10152460A1 (en)	2001-10-24	2001-10-24	stents
PCT/EP2002/011402 WO2003035133A1 (en)	2001-10-24	2002-10-11	Stents

Publications (2)

Publication Number	Publication Date
AU2002340549A1 true AU2002340549A1 (en)	2003-07-03
AU2002340549B2 AU2002340549B2 (en)	2007-11-29

Family

ID=7703557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002340549A Ceased AU2002340549B2 (en)	2001-10-24	2002-10-11	Stents

Country Status (22)

Country	Link
US (1)	US20050064006A1 (en)
EP (1)	EP1439869A1 (en)
JP (1)	JP2005506151A (en)
KR (1)	KR20040074977A (en)
CN (1)	CN1575189A (en)
AU (1)	AU2002340549B2 (en)
BR (1)	BR0213481A (en)
CA (1)	CA2464290A1 (en)
DE (1)	DE10152460A1 (en)
EC (1)	ECSP045075A (en)
EE (1)	EE200400080A (en)
HR (1)	HRP20040456A2 (en)
HU (1)	HUP0401760A3 (en)
IL (1)	IL161445A0 (en)
MA (1)	MA26341A1 (en)
MX (1)	MXPA04003755A (en)
NO (1)	NO20041984L (en)
NZ (1)	NZ532443A (en)
PL (1)	PL367968A1 (en)
RU (1)	RU2004115757A (en)
WO (1)	WO2003035133A1 (en)
ZA (1)	ZA200402989B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19962924A1 (en)	1999-12-24	2001-07-05	Bayer Ag	Substituted oxazolidinones and their use
DE10129725A1 (en) *	2001-06-20	2003-01-02	Bayer Ag	Combination therapy of substituted oxazolidinones
DE10300111A1 (en) *	2003-01-07	2004-07-15	Bayer Healthcare Ag	Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
DE10355461A1 (en) *	2003-11-27	2005-06-23	Bayer Healthcare Ag	Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) *	2004-12-24	2006-07-06	Bayer Healthcare Ag	Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) *	2005-01-31	2006-08-02	Bayer Health Care Aktiengesellschaft	Prevention and treatment of thromboembolic disorders
DE102005045518A1 (en) *	2005-09-23	2007-03-29	Bayer Healthcare Ag	New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
DE102005047561A1 (en)	2005-10-04	2007-04-05	Bayer Healthcare Ag	Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
CA2624310C (en)	2005-10-04	2014-01-07	Bayer Healthcare Ag	Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047558A1 (en) *	2005-10-04	2008-02-07	Bayer Healthcare Ag	Combination therapy of substituted oxazolidinones for the prophylaxis and treatment of cerebral circulatory disorders
US20070097252A1 (en) *	2005-10-31	2007-05-03	Silverstein D A	Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (en) *	2006-07-28	2008-01-31	Bayer Healthcare Ag	Coating of artificial surfaces of medical devices and equipment as well as cleaning and / or pretreatment of catheters and other medical aids and devices
DE102006051625A1 (en) *	2006-11-02	2008-05-08	Bayer Materialscience Ag	Combination therapy of substituted oxazolidinones
EP2220079A2 (en) *	2007-11-15	2010-08-25	Boehringer Ingelheim International GmbH	Substituted amides, manufacturing and use thereof as medicaments
US11654036B2 (en)	2020-05-26	2023-05-23	Elixir Medical Corporation	Anticoagulant compounds and methods and devices for their use
CN116157164A (en) *	2020-05-26	2023-05-23	万能医药公司	Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0623615T3 (en) *	1993-05-01	1999-12-13	Merck Patent Gmbh	Adhesion receptor antagonists
WO1998046628A1 (en) *	1997-04-14	1998-10-22	Cor Therapeutics, Inc.	SELECTIVE FACTOR Xa INHIBITORS
US6273913B1 (en) *	1997-04-18	2001-08-14	Cordis Corporation	Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) *	1998-04-16	2001-10-11	Robert Falotico	Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (en) *	1999-12-24	2001-07-05	Bayer Ag	Substituted oxazolidinones and their use
DE10105989A1 (en) *	2001-02-09	2002-08-14	Bayer Ag	Substituted oxazolidinones and their use

2001
- 2001-10-24 DE DE10152460A patent/DE10152460A1/en not_active Withdrawn
2002
- 2002-02-11 IL IL16144502A patent/IL161445A0/en unknown
- 2002-10-11 CA CA002464290A patent/CA2464290A1/en not_active Abandoned
- 2002-10-11 MX MXPA04003755A patent/MXPA04003755A/en not_active Application Discontinuation
- 2002-10-11 US US10/493,552 patent/US20050064006A1/en not_active Abandoned
- 2002-10-11 PL PL02367968A patent/PL367968A1/en not_active Application Discontinuation
- 2002-10-11 WO PCT/EP2002/011402 patent/WO2003035133A1/en not_active Ceased
- 2002-10-11 RU RU2004115757/15A patent/RU2004115757A/en not_active Application Discontinuation
- 2002-10-11 AU AU2002340549A patent/AU2002340549B2/en not_active Ceased
- 2002-10-11 BR BR0213481-0A patent/BR0213481A/en not_active IP Right Cessation
- 2002-10-11 HR HR20040456A patent/HRP20040456A2/en not_active Application Discontinuation
- 2002-10-11 KR KR10-2004-7006051A patent/KR20040074977A/en not_active Ceased
- 2002-10-11 CN CNA028210034A patent/CN1575189A/en active Pending
- 2002-10-11 HU HU0401760A patent/HUP0401760A3/en unknown
- 2002-10-11 JP JP2003537695A patent/JP2005506151A/en active Pending
- 2002-10-11 NZ NZ532443A patent/NZ532443A/en unknown
- 2002-10-11 EE EEP200400080A patent/EE200400080A/en unknown
- 2002-10-11 EP EP02774699A patent/EP1439869A1/en not_active Withdrawn
2004
- 2004-04-20 ZA ZA200402989A patent/ZA200402989B/en unknown
- 2004-04-22 EC EC2004005075A patent/ECSP045075A/en unknown
- 2004-04-23 MA MA27648A patent/MA26341A1/en unknown
- 2004-05-13 NO NO20041984A patent/NO20041984L/en not_active Application Discontinuation

Publication	Publication Date	Title
AU2002237877A1 (en)	2002-07-30	Stent
AU2002359573A1 (en)	2003-06-23	Non-foreshortening stent
AU2002341567A1 (en)	2003-05-12	Improved stent coating
AU2002328762A1 (en)	2003-07-03	Osteophilic implants
AU2002313565A1 (en)	2003-03-18	Putter-heads
AU2002354966A1 (en)	2003-03-03	Stents
AU2002340549A1 (en)	2003-07-03	Stents
IL161445A0 (en)	2004-09-27	Stents
AU2001218611A1 (en)	2002-06-11	Stent
AUPR560201A0 (en)	2001-07-12	Stent
AU2002313943A1 (en)	2003-02-24	Electromobile
AU2002226571A1 (en)	2002-08-12	Biligands
AU2001100406A4 (en)	2001-11-01	DriverSMS
AU2002313073A1 (en)	2002-12-03	Phytocystatin
AU2002342547A1 (en)	2003-05-19	Stent
HK1060969A (en)	2004-09-03	Monocanalicular stent
AU2002354051A1 (en)	2003-05-19	Stent
AU2002325537A1 (en)	2003-03-10	Stent
AU2002230107A1 (en)	2002-08-12	Stent
AU2002346155A1 (en)	2003-01-21	Stent
AU2002336327A1 (en)	2003-03-24	Endoprosthesis
AU2002230266A1 (en)	2002-08-19	Stent assembly
AU2002328991A1 (en)	2003-02-24	Prosthesis
AU2001100522A4 (en)	2001-11-22	e-Trans
AU2001100338A4 (en)	2001-10-04	Sunglove